Bigul

FORTIS HEALTHCARE LTD. - 532843 - Appointment of Company Secretary and Compliance Officer

Pursuant to Regulation 30 of SEBI LODR Regulation, 2015, this is to inform you that Mr. Murlee Manohar Jain has resigned from the position of Company Secretary & Compliance Officer of the Company and Mr. Satyendra Chauhan appointed as Company Secretary & Compliance Officer of the Company, as per detailed disclosure enclosed.
01-03-2024
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Board Meeting Outcome for Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Regarding Change In Company Secretary And Compliance Officer.

This is to inform you that the Board of Directors of the Company at its meeting held today i.e. March 1, 2024 have, inter-alia, considered the following: a) Noting of resignation of Mr. Murlee Manohar Jain from the position of Company Secretary & Compliance Officer of the Company with effect from February 29, 2024 (close of business hours). b) Approved the appointment of Mr. Satyendra Chauhan as Company Secretary & Compliance Officer of the Company with effect from March 1, 2024. The detailed disclosure is attached. This is for your information and record.
01-03-2024
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

In compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, this is inform you that the Company is dispatching the postal ballot notice to its members today on February 29, 2024, for seeking approval on resolutions as detailed in postal ballot notice, as enclosed.
29-02-2024
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations).

A copy of the announcement released by IHH parent company of Northern TK Ventures Pte Limited (promoter shareholder of the Company) is attached.
23-02-2024
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Regarding Consummation Of Transaction By A Subsidiary Of The Company In Respect Of Divestment Of Fortis Malar Hospital, Chennai And Related /Adjacent Assets.

Intimation regarding consummation of a transaction by a subsidiary of the Company in respect of divestment of Fortis Malar Hospital, Chennai and related/adjacent assets. The detailed disclosure is attached.
21-02-2024
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Intimation Under Reg. 30 Of SEBI (LODR) Regulations, 2015 In Relation To Withdrawal Of Draft Red Herring Prospectus (DRHP) By Agilus Diagnostics Limited, A Material Subsidiary Of The Company.

Intimation under reg. 30 of SEBI(LODR) Regulations, 2015 in relation to withdrawal of draft red herring prospectus (DRHP) by Agilus Diagnostics Limited, a material subsidiary of the Company. A detailed disclosure is attached.
13-02-2024

Fortis Q3 Results Review - Inline Hospital Ebitda; Margin, Occupancy To Scale Up: Prabhudas Lilladher

Steady ARPOB; occupancy dip QoQ due to seasonality and new bed addition
12-02-2024
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Pursuant to regulation 30 of SEBI (LODR) Regulations, 2015, please find attached the transcript of Investors/Analysts'' meet held on February 8, 2024.
10-02-2024
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Pursuant to Regulation 30 of SEBI (LODR) Regulation, 2015, please find enclosed transcript and audio recording link of Investors/Analysts'' meet held on February 8, 2024.
10-02-2024
Bigul

FORTIS HEALTHCARE LTD. - 532843 - Announcement under Regulation 30 (LODR)-Change in Management

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, Mr. Bipin Kumar appointed as Chief Information Officer of the Company w.e.f. February 09, 2024. A detailed disclosure is enclosed.
09-02-2024
Next Page
Close

Let's Open Free Demat Account